Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02397278 · ClinicalTrials.gov registry record · NA
Intra Articular Injections With Platelet Rich Plasma in Patients With Juvenile Osteochondritis Dissecans of the Knee
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT02397278 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 15 participants.
The verdict
NCT02397278, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This study plans to learn more about ways to treat a joint problem in the knee called Juvenile Osteochondritis Dissecans (OCD). The goal of this study is to see if injecting platelet-rich plasma (PRP) into the knee can help knee cartilage heal faster, and will try to determine whether the injections lead to improvements in pain, performance of activities of daily living, improvements is sports activities and overall function and symptoms reduction. The investigators will compare PRP treatment to conservative therapy.
Interventions
- DRUG Platelet rich plasma (PRP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2015-03 |
| Est. Completion | 2020-01-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02397278
The ClinicalTrials.gov registry entry for NCT02397278 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Platelet rich plasma (PRP) is the first listed.
NCT02397278 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02397278 about?
NCT02397278 is a clinical study titled "Intra Articular Injections With Platelet Rich Plasma in Patients With Juvenile Osteochondritis Dissecans of the Knee". This study plans to learn more about ways to treat a joint problem in the knee called Juvenile Osteochondritis Dissecans (OCD). The goal of this study is to see if injecting platelet-rich plasma (PRP) into the knee can help knee cartilage heal faster, and will try to determine whether the injections...
What is the current status of trial NCT02397278?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2015-03. Estimated completion is 2020-01-08.
What interventions are being tested in trial NCT02397278?
The interventions under investigation include: Platelet rich plasma (PRP) (DRUG).
Who is sponsoring clinical trial NCT02397278?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.